SuperworthLexicon Pharmaceuticals shares outstanding LXRX
Diluted shares outstanding, averaged over each quarter, from 2012.
- Latest quarter, to Jun 30, 2026
- 437.7M
- On a year earlier
- +20.4%
- more shares
Lexicon Pharmaceuticals had 437.7M diluted shares outstanding on average in Q2 FY26, the quarter to Jun 30, 2026.
That is 20.4% more than a year earlier, so each share owns a little less of the company.
Shares outstanding over time
Fiscal year by fiscal year
| Fiscal year | Shares, fourth quarter | Change |
|---|---|---|
| FY2025 | 363.4M | +1% |
| FY2024 | 361.5M | +48% |
| FY2023 | 244.9M | +30% |
| FY2022 | 188.7M | +27% |
| FY2021 | 148.9M | +22% |
| FY2020 | 122.4M | +15% |
| FY2019 | 106.3M | +0% |
| FY2018 | 105.9M | +0% |
| FY2017 | 105.6M | +1% |
| FY2016 | 104.1M | +0% |
| FY2015 | 103.6M | +22% |
| FY2014 | 84.8M | +16% |
| FY2013 | 73.4M | +1% |
| FY2012 | 72.5M | n/a |
Each fiscal year is the twelve months to its fourth quarter, shown as the fourth quarter's average share count.
Quarter by quarter
| Quarter | Ended | Shares outstanding | On a year earlier |
|---|---|---|---|
| Q2 FY26 | 437.7M | +20% | |
| Q1 FY26 | 400.2M | +11% | |
| Q4 FY25 | 363.4M | +1% | |
| Q3 FY25 | 363.4M | +1% | |
| Q2 FY25 | 363.6M | +17% | |
| Q1 FY25 | 362.1M | +48% | |
| Q4 FY24 | 361.5M | +48% | |
| Q3 FY24 | 361.5M | +48% | |
| Q2 FY24 | 310.8M | +52% | |
| Q1 FY24 | 245.4M | +30% | |
| Q4 FY23 | 244.9M | +30% | |
| Q3 FY23 | 244.9M | +40% |
What the shares outstanding tells you
Diluted shares outstanding, averaged over the period. Fewer shares means each one owns more of the company.
A falling count usually means buybacks. A rising one means stock pay, acquisitions paid in shares or new shares sold.
More on Lexicon Pharmaceuticals
Valuation data, not investment advice. Prices as of . Reported figures come from the company's filings with the SEC.